Business description
HAEMATO AG was founded in 1993 and is a stock exchange quoted pharmaceutical company. The company is listed on the Frankfurt Stock Exchange in the Entry Standard (Open Market) and is based in Schönefeld / Germany. HAEMATO AG is active within the pharmaceutical industry and is specialized in the growing markets of patent protected and patent free medications. The core focus lies in the therapeutic areas oncology, HIV/AIDS and other chronic diseases.
Management board & Supervisory board
| CEO |
| Patrick Brenske |
| Management board |
| Attila Strauss |
| Supervisory board |
| Andrea Grosse, Prof. Dr. Dr. Sabine Meck, Uwe Zimdars |
Company data
| Name: |
HAEMATO AG |
| Address: |
Lilienthalstraße 5c,D-12529 Schönefeld |
| Phone: |
+49-30-677-9867-600 |
| Fax: |
+49-30-677-9867-707 |
| E-mail: |
service@haemato.de
|
| Internet: |
www.haemato.de |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
12-31 |
| Free Float: |
24.20% |
| IPO date: |
2005-12-05 |
Investor relations
| Name: |
- |
| IR phone: |
- |
| IR Fax: |
- |
| IR e-mail: |
ir@haemato.de
|
